![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/519 | (2006.01) |
A61P 35/00 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 27/00 | (2006.01) | ||
A61P 19/00 | (2006.01) | ||
A61P 1/00 | (2006.01) | ||
A61P 17/00 | (2006.01) |
(11) | Number of the document | 3513793 |
(13) | Kind of document | T |
(96) | European patent application number | 18215449.2 |
Date of filing the European patent application | 2012-08-31 | |
(97) | Date of publication of the European application | 2019-07-24 |
(45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
(46) | Date of publication of the claims translation | 2021-06-10 |
(30) | Number | Date | Country code |
201161530866 P | 2011-09-02 | US | |
201261594882 P | 2012-02-03 | US | |
201261677445 P | 2012-07-30 | US |
(72) |
LI, Yun-Long, US
YAO, Wenqing, US
COMBS, Andrew, P., US
YUE, Eddy, W., US
MEI, Song, US
ZHU, Wenyu, US
GLENN, Joseph, US
MADUSKUIE, Thomas, P., Jr., US
SPARKS, Richard, B., US
DOUTY, Brent, US
HE, Chunhong, US
|
(73) |
Incyte Holdings Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Heterociklilaminai, kaip PI3K inhibitoriai |
HETEROCYCLYLAMINES AS PI3K INHIBITORS |
Payment date | Validity (years) | Amount | |
2025-08-25 | 14 | 289.00 EUR |
2026-08-31 |